Ardelyx Raises Concerns Over GUARD Model's Potential Impact on Biopharmaceutical Innovation
2026-03-01
PubComNonGov2026-03-01
Carter Struck
WASHINGTON, March 1 -- Ardelyx Inc., a biopharmaceutical firm headquartered in Waltham, Massachusetts, has submitted a public comment letter to the Centers for Medicare and Medicaid Services (CMS) exp . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, March 1 -- Ardelyx Inc., a biopharmaceutical firm headquartered in Waltham, Massachusetts, has submitted a public comment letter to the Centers for Medicare and Medicaid Services (CMS) exp . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and individuals; as well as 'gathered' public policy information, including news releases, reports, speeches. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
Copyright © Targeted News Service, 2026